ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,189, issued on Nov. 18, was assigned to The Regents of the University of Michigan (Ann Arbor, Mich.).
"Treatment and prevention of capillary malformation-arteriovenous malformation" was invented by Philip King (Ann Arbor, Mich.) and Di Chen (Ann Arbor, Mich.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for the treatment and prevention of vascular lesions arising from RASA1 and/or EPHB4 mutations and associated with capillary malformation-arteriovenous malformation (CM-AVM)."
The patent was filed on Feb. 12, 2021, under Application No. 17/798,502.
*For further information, including images, charts and tables, please vi...